Keto, Ivermectin, & Fenbendazole: New Cancer Treatment Protocol Gains Momentum
16th September 2025
In 2023, according to the US Centers for Disease Control, 613,349 Americans died of cancer. That number is projected to increase to over 618,000 this year. As a result, medical research has been focused on the development of cancer treatment protocols for decades for all types of cancer.
The National Cancer Institute’s Cancer Trials Support Unit (CTSU) and the National Institute of Health’s ClinicalTrials.gov website list hundreds of active protocols, with 457 NCI-supported protocols noted in clinical trial databases for various cancer types and stages.
For example, there are approximately a dozen known treatment protocols for Stage 4 prostate cancer that focus on managing the disease since it is considered to be incurable. For context, the American Cancer Society’s estimates for prostate cancer in the US for 2025 are about 313,780 new cases and about 35,770 projected deaths.
Medical researchers are continually developing potentially breakthrough cancer protocols. This is the true story of one man’s experience with a new protocol that exploits repurposed drugs.